{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:48:15Z","timestamp":1794894495067,"version":"4.9.1"},"reference-count":54,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Vicerrector\u00eda de Investigaci\u00f3n y Desarrollo VRID\u2013UdeC","award":["2024001181INI"],"award-info":[{"award-number":["2024001181INI"]}]},{"name":"Commission of the European Community. MediHealth Project","award":["691158"],"award-info":[{"award-number":["691158"]}]},{"name":"CNRS"},{"DOI":"10.13039\/501100003768","name":"University of Strasbourg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Interdisciplinary Thematic Institute IMS"},{"name":"the drug discovery and development institute"},{"name":"IdEx Unistra","award":["ANR-10-IDEX-0002"],"award-info":[{"award-number":["ANR-10-IDEX-0002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Antimicrobial resistance (AMR) remains a major threat to modern medicine, fueled by the excessive use of antibiotics and the spread of multidrug-resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA). In this study, we designed and synthesized a series of 2-aryl-4-aminoquinazoline derivatives bearing an aminoalkylimidazole linker, combining two pharmacophoric motifs associated with antimicrobial activity. Starting from anthranilamide, the compounds were prepared in three straightforward steps, affording good yields and high purity. Their structures were confirmed by FT-IR spectroscopy, 1H and 13C nuclear magnetic resonance (NMR), and high-resolution mass spectrometry (HRMS). Biological evaluation showed that series 5 exhibited strong selectivity toward S. aureus, with compounds 5c and 5d displaying minimum inhibitory concentrations (MICs) between 2.2 and 4.4 \u00b5M. No significant activity was observed against other tested strains. Cytotoxicity assays in HepG2 cells revealed moderate to low inhibition. Molecular docking indicated preferential binding to dihydrofolate reductase (DHFR) and relevant interactions with topoisomerase IV, resembling reference inhibitors. ADME analysis predicted favourable absorption, blood\u2013brain barrier permeability, and compliance with Lipinski\u2019s rules.<\/jats:p>","DOI":"10.3390\/ijms27062529","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:53:31Z","timestamp":1773140011000},"page":"2529","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synthesis of 2-Aryl-4-aminoquinazolines: Design, Molecular Docking, and In Vitro Assessment of Antibacterial and Cytotoxic Potential"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-5643","authenticated-orcid":false,"given":"Felipe","family":"Verdugo","sequence":"first","affiliation":[{"name":"Departamento de Qu\u00edmica Org\u00e1nica, Facultad de Ciencias Qu\u00edmicas, Universidad de Concepci\u00f3n, Edmundo Larenas 129, Concepci\u00f3n 4070371, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Braillon","sequence":"additional","affiliation":[{"name":"CNRS, UMR 7242, Biotechnologie et Signalisation Cellulaire, Institut de Recherche de l\u2019Ecole de Biotechnologie de Strasbourg, Universit\u00e9 de Strasbourg, 67400 Illkirch-Graffenstaden, France"},{"name":"UMR 7200 Laboratoire d\u2019Innovation Th\u00e9rapeutique, CNRS, Strasbourg Drug Discovery and Development Institute (IMS), Universit\u00e9 de Strasbourg, 67400 Illkirch-Graffenstaden, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Mahjoub","sequence":"additional","affiliation":[{"name":"CNRS, UMR 7242, Biotechnologie et Signalisation Cellulaire, Institut de Recherche de l\u2019Ecole de Biotechnologie de Strasbourg, Universit\u00e9 de Strasbourg, 67400 Illkirch-Graffenstaden, France"},{"name":"Laboratory of Human Genome and Multifactorial Diseases (LR12ES07), Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-8027","authenticated-orcid":false,"given":"Alejandro","family":"Castro-Alvarez","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias Precl\u00ednicas, Facultad de Medicina, Universidad de La Frontera, Temuco 4811230, Chile"},{"name":"Millennium Nucleus Bioproducts, Genomics and Environmental Microbiology (BioGEM), Valpara\u00edso 2390123, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-8551","authenticated-orcid":false,"given":"R\u00e9gine","family":"Janel-Bintz","sequence":"additional","affiliation":[{"name":"CNRS, UMR 7242, Biotechnologie et Signalisation Cellulaire, Institut de Recherche de l\u2019Ecole de Biotechnologie de Strasbourg, Universit\u00e9 de Strasbourg, 67400 Illkirch-Graffenstaden, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5912-361X","authenticated-orcid":false,"given":"Pierre","family":"Fechter","sequence":"additional","affiliation":[{"name":"CNRS, UMR 7242, Biotechnologie et Signalisation Cellulaire, Institut de Recherche de l\u2019Ecole de Biotechnologie de Strasbourg, Universit\u00e9 de Strasbourg, 67400 Illkirch-Graffenstaden, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-4852","authenticated-orcid":false,"given":"Pascal","family":"Villa","sequence":"additional","affiliation":[{"name":"PCBIS Plateforme de Chimie Biologie Int\u00e9grative de Strasbourg, UAR 3286 CNRS\/Universit\u00e9 de Strasbourg, 67000 Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-8308","authenticated-orcid":false,"given":"Claudio A.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica Org\u00e1nica, Facultad de Ciencias Qu\u00edmicas, Universidad de Concepci\u00f3n, Edmundo Larenas 129, Concepci\u00f3n 4070371, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego A.","family":"Donoso-Ruiz","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica Org\u00e1nica, Facultad de Ciencias Qu\u00edmicas, Universidad de Concepci\u00f3n, Edmundo Larenas 129, Concepci\u00f3n 4070371, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6887-1396","authenticated-orcid":false,"given":"Marcia","family":"P\u00e9rez-Fehrmann","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Facultad de Ciencias, Universidad Cat\u00f3lica del Norte, Avda. Angamos 0610, Antofagasta 1270709, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-547X","authenticated-orcid":false,"given":"V\u00edctor","family":"Kesternich","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Facultad de Ciencias, Universidad Cat\u00f3lica del Norte, Avda. Angamos 0610, Antofagasta 1270709, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1596-4887","authenticated-orcid":false,"given":"Sergio","family":"Ortiz","sequence":"additional","affiliation":[{"name":"UMR 7200 Laboratoire d\u2019Innovation Th\u00e9rapeutique, CNRS, Strasbourg Drug Discovery and Development Institute (IMS), Universit\u00e9 de Strasbourg, 67400 Illkirch-Graffenstaden, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7449-6334","authenticated-orcid":false,"given":"Ronald","family":"Nelson","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Facultad de Ciencias, Universidad Cat\u00f3lica del Norte, Avda. Angamos 0610, Antofagasta 1270709, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global Burden of Bacterial Antimicrobial Resistance 1990\u20132021: A Systematic Analysis with Forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.micpath.2022.105923","article-title":"Emergent Crisis of Antibiotic Resistance: A Silent Pandemic Threat to 21st Century","volume":"174","author":"Akram","year":"2023","journal-title":"Microb. Pathog."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus Aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Liu, A., Garrett, S., Hong, W., and Zhang, J. (2024). Staphylococcus Aureus Infections and Human Intestinal Microbiota. Pathogens, 13.","DOI":"10.3390\/pathogens13040276"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ahmad-Mansour, N., Loubet, P., Pouget, C., Dunyach-Remy, C., Sotto, A., Lavigne, J.P., and Molle, V. (2021). Staphylococcus Aureus Toxins: An Update on Their Pathogenic Properties and Potential Treatments. Toxins, 13.","DOI":"10.3390\/toxins13100677"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14686996.2021.1978801","article-title":"Current Approaches for the Exploration of Antimicrobial Activities of Nanoparticles","volume":"22","author":"Rosli","year":"2021","journal-title":"Sci. Technol. Adv. Mater."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-L\u00f3pez, E., Gomes, D., Esteruelas, G., Bonilla, L., Lopez-Machado, A.L., Galindo, R., Cano, A., Espina, M., Ettcheto, M., and Camins, A. (2020). Metal-Based Nanoparticles as Antimicrobial Agents: An Overview. Nanomaterials, 10.","DOI":"10.3390\/nano10020292"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s11671-024-04021-9","article-title":"From Nature to Nanomedicine: Bioengineered Metallic Nanoparticles Bridge the Gap for Medical Applications","volume":"19","author":"Patel","year":"2024","journal-title":"Discov. Nano"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Parvin, N., Joo, S.W., and Mandal, T.K. (2025). Nanomaterial-Based Strategies to Combat Antibiotic Resistance: Mechanisms and Applications. Antibiotics, 14.","DOI":"10.3390\/antibiotics14020207"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.12.4.564","article-title":"Plant Products as Antimicrobial Agents","volume":"12","author":"Cowan","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1039\/D2NP00090C","article-title":"Recent Advances in the Discovery of Plant-Derived Antimicrobial Natural Products to Combat Antimicrobial Resistant Pathogens: Insights from 2018\u20132022","volume":"40","author":"Woo","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"ref_12","first-page":"e02395","article-title":"A Comprehensive Review on Medicinal Plant Extracts as Antibacterial Agents: Factors, Mechanism Insights and Future Prospects","volume":"26","author":"Zouine","year":"2024","journal-title":"Sci. Afr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12361","DOI":"10.1021\/jacs.4c16035","article-title":"Metal-Based Approaches for the Fight against Antimicrobial Resistance: Mechanisms, Opportunities, and Challenges","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41570-023-00463-4","article-title":"Metals to Combat Antimicrobial Resistance","volume":"7","author":"Frei","year":"2023","journal-title":"Nat. Rev. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/chemistry2040056","article-title":"New Antimicrobial Strategies Based on Metal Complexes","volume":"2","author":"Claudel","year":"2020","journal-title":"Chemistry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/D4RA07449A","article-title":"Metal Compounds as Antimicrobial Agents: \u2018Smart\u2019 Approaches for Discovering New Effective Treatments","volume":"15","author":"Vitali","year":"2025","journal-title":"RSC Adv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/acscentsci.5c01046","article-title":"Hybrid Antibiotics Targeting the Bacterial Ribosome","volume":"11","author":"Yeon","year":"2025","journal-title":"ACS Cent. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00077-17","DOI":"10.1128\/CMR.00077-17","article-title":"Antibiotic Hybrids: The Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?","volume":"31","author":"Domalaon","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tamboura, B., Yudaev, P., Butorova, I., Klyukin, B., Chuev, V., and Chistyakov, E. (2025). Hexaallylaminocyclotriphosphazene-Modified Dental Compositions for 3D Printing of Dental Crowns. Polymers, 18.","DOI":"10.3390\/polym18010053"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yudaev, P., Tupikov, A., and Chistyakov, E. (2025). Organocyclophosphazenes and Materials Based on Them for Pharmaceuticals and Biomedicine. Biomolecules, 15.","DOI":"10.3390\/biom15020262"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial Resistance: A Global Multifaceted Phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1021\/acsinfecdis.3c00189","article-title":"Small-Molecule Antibiotic Drug Development: Need and Challenges","volume":"9","author":"Bergkessel","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105190","DOI":"10.1016\/j.arabjc.2023.105190","article-title":"Advances in Synthesis and Biological Activities of Quinazoline Scaffold Analogues: A Review","volume":"16","author":"Ramesh","year":"2023","journal-title":"Arab. J. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101955","DOI":"10.1016\/j.rechem.2024.101955","article-title":"Quinazoline Scaffold as a Target for Combating Microbial Resistance: Synthesis and Antimicrobial Profiling of Quinazoline Derivatives","volume":"13","author":"Halappanavar","year":"2025","journal-title":"Results Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"105422","DOI":"10.1016\/j.bioorg.2021.105422","article-title":"Novel 2,4-Disubstituted Quinazoline Analogs as Antibacterial Agents with Improved Cytotoxicity Profile: Optimization of the 2,4-Substituents","volume":"117","author":"Aboushady","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"111499","DOI":"10.1016\/j.inoche.2023.111499","article-title":"Design, Synthesis, Molecular Docking, Biological Evaluation, DFT and ADME Studies of Novel Bisquinazolinone Derivatives","volume":"158","author":"Ayoob","year":"2023","journal-title":"Inorg. Chem. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1080\/14756366.2022.2084088","article-title":"Discovery of N-Quinazolinone-4-Hydroxy-2-Quinolone-3-Carboxamides as DNA Gyrase B-Targeted Antibacterial Agents","volume":"37","author":"Xue","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Al-Ghamdi, H.A., Almughem, F.A., Alshabibi, M.A., Bakr, A.A., Alshehri, A.A., Aodah, A.H., Al Zahrani, N.A., Tawfik, E.A., and Damiati, L.A. (2024). Synthesis and Biological Evaluation of Novel Imidazole Derivatives as Antimicrobial Agents. Biomolecules, 14.","DOI":"10.3390\/biom14091198"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rossi, R., and Ciofalo, M. (2020). An Updated Review on the Synthesis and Antibacterial Activity of Molecular Hybrids and Conjugates Bearing Imidazole Moiety. Molecules, 25.","DOI":"10.3390\/molecules25215133"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ejmech.2017.11.100","article-title":"Synthesis and Biological Evaluation of Coumarin Derivatives Containing Imidazole Skeleton as Potential Antibacterial Agents","volume":"143","author":"Hu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Valls, A., Andreu, J.J., Falomir, E., Luis, S.V., Atri\u00e1n-Blasco, E., Mitchell, S.G., and Altava, B. (2020). Imidazole and Imidazolium Antibacterial Drugs Derived from Amino Acids. Pharmaceuticals, 13.","DOI":"10.3390\/ph13120482"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106310","DOI":"10.1016\/j.bioorg.2022.106310","article-title":"Design, Synthesis and Molecular Modeling Study of Certain EGFR Inhibitors with a Quinazolinone Scaffold as Anti-Hepatocellular Carcinoma and Radio-Sensitizers","volume":"131","author":"Ghorab","year":"2023","journal-title":"Bioorg. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejmech.2013.06.057","article-title":"Quinazoline-Based Multi-Tyrosine Kinase Inhibitors: Synthesis, Modeling, Antitumor and Antiangiogenic Properties","volume":"67","author":"Conconi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"104848","DOI":"10.1016\/j.bioorg.2021.104848","article-title":"Design, Synthesis and Evaluation of Anti-Proliferative Activity of 2-Aryl-4-aminoquinazoline Derivatives as EGFR Inhibitors","volume":"112","author":"Zhou","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bioorg.2018.10.028","article-title":"2-Aryl-Quinazolin-4(3H)-Ones as an Inhibitor of Leishmania Folate Pathway: In Vitro Biological Evaluation, Mechanism Studies and Molecular Docking","volume":"83","author":"Romero","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"128531","DOI":"10.1016\/j.bmcl.2022.128531","article-title":"Novel 2,4-Disubstituted Quinazoline Analogs as Antibacterial Agents with Improved Cytotoxicity Profile: Modification of the Benzenoid Part","volume":"59","author":"Megahed","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.bmcl.2017.05.064","article-title":"Synthesis and Structure\u2014Activity Relationship Study of Novel Quinazolinone-Based Inhibitors of MurA","volume":"27","author":"Hrast","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/12102413","article-title":"Antibacterial Activity of Some 3-(Arylideneamino)-2-Phenylquinazoline-4(3H)-Ones: Synthesis and Preliminary QSAR Studies","volume":"12","author":"Nanda","year":"2007","journal-title":"Molecules"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/acs.jmedchem.6b00372","article-title":"Structure\u2013Activity Relationship for the 4(3H)-Quinazolinone Antibacterials","volume":"59","author":"Bouley","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ejmech.2018.08.070","article-title":"Synthesis of 1,2,3-Triazole Linked 4(3H)-Quinazolinones as Potent Antibacterial Agents against Multidrug-Resistant Staphylococcus aureus","volume":"157","author":"Gatadi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/j.ejmech.2010.04.014","article-title":"Novel 6,8-Dibromo-4(3H)Quinazolinone Derivatives of Anti-Bacterial and Anti-Fungalactivities","volume":"45","author":"Mohameda","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bmc.2008.11.012","article-title":"Discovery and Structure-Activity Relationships of 4-Aminoquinazoline Derivatives, a Novel Class of Opioid Receptor like-1 (ORL1) Antagonists","volume":"17","author":"Okano","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.ejmech.2008.07.023","article-title":"Synthesis and in Vitro Antitumor Activities of Novel 4-Anilinoquinazoline Derivatives","volume":"44","author":"Chandregowda","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/AAC.00250-20","article-title":"Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin\/Linezolid","volume":"64","author":"Wittke","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"La Monica, G., Gallo, A., Bono, A., Alamia, F., Lauria, A., Alduina, R., and Martorana, A. (2025). Novel Antibacterial 4-Piperazinylquinoline Hybrid Derivatives Against Staphylococcus Aureus: Design, Synthesis, and In Vitro and In Silico Insights. Molecules, 30.","DOI":"10.3390\/molecules30010028"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, Efficient Generation of High-quality Atomic Charges. AM1-BCC Model: II. Parameterization and Validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J. Comput. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/prot.22383","article-title":"Structural Comparison of Chromosomal and Exogenous Dihydrofolate Reductase from Staphylococcus aureus in Complex with the Potent Inhibitor Trimethoprim","volume":"76","author":"Heaslet","year":"2009","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly Accurate Protein Structure Prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Carr, S.B. (2007). Crystal Structure of a 59 KDa Fragment of Topoisomerase IV Subunit A (GrlA) from Staphylococcus aureus. RCSB Protein Data Bank.","DOI":"10.2210\/pdb2inr\/pdb"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Najmudin, S., Pan, X.S., Wang, B., Chayen, N.E., Fisher, L.M., and Sanderson, M.R. (2024). High Resolution Structure of the Streptococcus pneumoniae Topoisomerase IV-DNA Complex with the Novel Fluoroquinolone Delafloxacin. RCSB Protein Data Bank.","DOI":"10.2210\/pdb8qmc\/pdb"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2529\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:41:17Z","timestamp":1773294077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27062529"],"URL":"https:\/\/doi.org\/10.3390\/ijms27062529","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}